Published in

Royal Society of Chemistry, Dalton Transactions, 48(47), p. 17367-17381, 2018

DOI: 10.1039/c8dt03360a

Links

Tools

Export citation

Search in Google Scholar

N,N-Dialkylbenzimidazol-2-ylidene platinum complexes – effects of alkyl residues and ancillarycis-ligands on anticancer activity

Journal article published in 2018 by Tobias Rehm, Matthias Rothemund, Alexander Bär, Thomas Dietel ORCID, Rhett Kempe, Hana Kostrhunova ORCID, Viktor Brabec ORCID, Jana Kasparkova ORCID, Rainer Schobert ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Benzimidazol-2-ylidene platinum complexes exhibit anticancer activity, which is tuneablevia N-alkyl residues and ancillary ligands and is different from that of cisplatin.